Lancellotti P, Lempereur M, Marchetta S, Dulgheru R
Service de Cardiologie et GIGA Cardiovasculaire, CHU Liège, Belgique.
Service de Cardiologie , CHU Liège, Belgique.
Rev Med Liege. 2019;74(S1):S82-S86.
Paravalvular leaks (PVL) are a serious complication after surgical or transcatheter aortic valve replacement. They are mostly small and unimportant. When they manifest clinically (1 to 5 % of PVL), they can become responsible for severe hemolytic anaemia or cause congestive heart failure. For years, surgical re-intervention has been considered the treatment of choice for symptomatic patients with PVL. However, surgical re-intervention is associated with a high risk of morbidity and mortality. Percutaneous PVL closure is a less invasive alternative to surgical re-intervention. The safety and feasibility of percutaneous PVL closure has been confirmed in several studies. In this article, we discuss the issue of PVL and their percutaneous management.
瓣周漏是外科手术或经导管主动脉瓣置换术后的一种严重并发症。多数情况下瓣周漏较小且无重要影响。当出现临床症状时（占瓣周漏的1%至5%），可导致严重溶血性贫血或引起充血性心力衰竭。多年来，手术再次干预一直被认为是有症状的瓣周漏患者的首选治疗方法。然而，手术再次干预与较高的发病和死亡风险相关。经皮瓣周漏封堵术是一种侵入性较小的手术再次干预替代方法。多项研究已证实经皮瓣周漏封堵术的安全性和可行性。在本文中，我们讨论瓣周漏问题及其经皮治疗方法。
